The safety and efficacy of familial haploidentical (FHI) stem cell transplantation utilizing CD34 enrichment and CD3 addback in patients with high risk sickle cell disease (SCD) (IND 14359)

被引:0
|
作者
Cairo, M. [1 ]
Talano, J-A [2 ]
Moore, T. B. [3 ]
Baxter-Lowe, L. A. [4 ]
Keever-Taylor, C. [2 ]
Grossman, B.
Weinberg, R. [5 ]
Morris, E. [1 ]
Shi, Q. [6 ]
Shenoy, S. [7 ]
机构
[1] New York Med Coll, Valhalla, NY 10595 USA
[2] Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA
[3] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA
[4] Childrens Hosp Los Angeles, Dept Pathol, Los Angeles, CA 90027 USA
[5] New York Blood Ctr, New York, NY USA
[6] New York Med Coll, Dept Biostat, Valhalla, NY 10595 USA
[7] Washington Univ, Dept Pediat, St Louis, MO 63130 USA
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
P601
引用
收藏
页码:S438 / S438
页数:1
相关论文
共 50 条
  • [21] Stable Pulmonary Function after Myeloimmunosupressive Conditioning (MIC) and Familial Haploidentical (FHI) Transplantation Utilizing CD34+Enrichment and PBMC (CD3) Add Back in Children and Young Adults with High Risk (HR) Sickle Cell Disease (SCD)
    Flower, Allyson
    Talano, Julie-An M.
    Moore, Theodore B.
    Shenoy, Shalini
    Broglie, Larisa
    Mahanti, Harshini
    Morris, Erin
    Fabricatore, Sandra
    Dozor, Allen J.
    Cairo, Mitchell S.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S222 - S222
  • [22] Assessment of Safety and Efficacy of PBSC Mobilization with G-CSF and CD34+Enrichment and Pbmnc (CD3+) Addback in Familial Haploidentical (FHI) Adult Donors with Sickle Cell Disease Trait (SCDT) Prior to Allogeneic HSCT of High-Risk SCD Patients
    Long, Bronwyn Gillian
    Flower, Allyson
    Fabricatore, Sandra
    Morris, Erin
    Mahanti, Harshini
    Shi, Qiuhu
    Keever-Taylor, Carolyn A.
    Weinberg, Rona S.
    Grossman, Brenda
    Talano, Julie-An M.
    Shenoy, Shalini
    Moore, Theodore B.
    Ayello, Janet
    Semidei-Pomales, Mildred
    van de Ven, Carmella
    Cairo, Mitchell S.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [23] Assessment of Safety and Efficacy of PBSC Mobilization with G-CSF and CD34+Enrichment and Pbmnc (CD3+) Addback in Familial Haploidentical (FHI) Adult Donors with Sickle Cell Disease Trait (SCDT) Prior to Allogeneic HSCT of High-Risk SCD Patients
    Long, Bronwyn
    Fabricatore, Sandra
    Flower, Allyson
    Morris, Erin
    Mahanti, Harshini
    Shi, Qiuhu
    Keever-Taylor, Carolyn
    Weinberg, Rona S.
    Grossman, Brenda
    Talano, Julie-An M.
    Shenoy, Shalini
    Moore, Theodore B.
    Ayello, Janet
    Semidei-Pomales, Mildred
    van de Ven, Carmella
    Cairo, Mitchell S.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S162 - S163
  • [24] Determining the Safety and Efficacy of Prophylactic Defibrotide Administration in Children, Adolescents, and Young Adults with Sickle Cell Disease Following Myeloimmunoablative Conditioning (MAC) and Haploidentical Stem Cell Transplantation Utilizing CD34+Selection and T-Cell (CD3) Addback (IND127812)
    Milner, Jordan
    Hung, Justine
    Ayello, Janet
    Shi, Qiuhu
    Talano, Julie-An M.
    Moore, Theodore B.
    Friedman, Deborah
    Dozor, Allen J.
    Klejmont, Liana
    Mahanti, Harshini
    Morris, Erin
    Fabricatore, Sandra
    Mintzer, Elizabeth
    Flower, Allyson
    Cooke, Kenneth R.
    Cairo, Mitchell S.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S212 - S213
  • [25] DETERMINING THE SAFETY AND EFFICACY OF PROPHYLACTIC DEFIBROTIDE ADMINISTRATION IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH SICKLE CELL DISEASE FOLLOWING MYELOIMMUNOABLATIVE CONDITIONING (MAC) AND HAPLOIDENTICAL STEM CELL TRANSPLANTATION UTILIZING CD34+SELECTION AND T-CELL (CD3) ADDBACK (IND127812)
    Milner, Jordan
    Hung, Justine
    Ayello, Janet
    Shi, Qiuhu
    Talano, Julie
    Moore, Theodore
    Friedman, Deborah
    Dozor, Alan
    Klejmont, Liana
    Mahanti, Harshini
    Morris, Erin
    Fabricatore, Sandra
    Mintzer, Elizabeth
    Flower, Allyson
    Cooke, Kenneth R.
    Cairo, Mitchell S.
    [J]. PEDIATRIC BLOOD & CANCER, 2020, 67 : S228 - S228
  • [26] Familial Haploidentical (FHI) Allogeneic Stem Cell Transplantation Utilizing CD34 Enrichment and T Cell Addbacic in Children, Adolescents & Adults with High-Risk Sickle Cell Disease. Rapid Engraftment, Low Incidence of Agvhd, and Sustained Donor Chimerism
    Cairo, Mitchell S.
    Talano, Julie-An M.
    Moore, Theodore B.
    Weinberg, Rona
    Keever-Taylor, Carolyn A.
    Grossman, Brenda
    Baxter-Lowe, Lee Ann
    Parsons, Susan K.
    Braniecki, Suzanne
    Morris, Erin
    Brand, Phyllis
    Fabricatore, Sandra
    Ayello, Janet
    Semidei-Pomales, Mildred
    van de Ven, Carmella
    Abikoff, Cori
    Shenoy, Shalini
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S367 - S368
  • [27] Neurocognitive & Neurological Outcomes in Children, Adolescents & Young Adults with High-Risk SCD Who Have Undergone Familial Haploidentical (FHI) Allosct Utilizing CD34 Enrichment and T Cell Addback Following Myeloimmunoablative Conditioning (MAC)
    Braniecki, Suzanne
    Talano, Julie-An M.
    Moore, Theodore B.
    Weinberg, Rona
    Keever-Taylor, Carolyn A.
    Grossman, Brenda
    Baxter-Lowe, Lee Ann
    Parsons, Susan K.
    Morris, Erin
    Brand, Phyllis
    Fabricatore, Sandra
    Ayello, Janet
    Semidei-Pomales, Mildred
    van de Ven, Carmella
    Abikoff, Cori
    Shenoy, Shalini
    McKinstry, Robert
    Cairo, Mitchell S.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S192 - S193
  • [28] Processing of G-CSF Mobilized Peripheral Blood Stem Cells (PBSC) from Parental Haploidentical Sickle Cell Trait Donors Undergoing CD34 Enrichment with T cell Addback in Children, Adolescents and Adults with HighRisk Sickle Cell Disease (IND 14359)
    Ayello, J.
    Keever-Taylor, C.
    Weinberg, R.
    Grossman, B. J.
    Shenoy, S.
    Talano, J.
    Moore, T. B.
    Fabricatore, S.
    Semidei-Pomales, M.
    Cairo, M.
    [J]. TRANSFUSION, 2016, 56 : 5A - 5A
  • [29] Reduced Intensity Haploidentical Stem Cell Transplantation with CD34 Selection and Addback of Regulatory and Conventional T Cells
    Boyer, Michael
    Jacobson, Pam
    Marvin, James
    Hsieh, Fen Fen
    Preslar, Amber
    Pulsipher, Michael A.
    Hildebrandt, Gerhard C.
    Zander, Axel
    Couriel, Daniel R.
    Reems, JoAnna
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S379 - S380
  • [30] NEUROCOGNITIVE OUTCOMES IN CHILDREN, ADOLESCENTS & YOUNG ADULTS WITH HIGH-RISK SICKLE CELL DISEASE (SCD) FOLLOWING FAMILIAL HAPLOIDENTICAL (FHI) STEM CELL TRANSPLANTATION: A PROSPECTIVE STUDY FROM PRE HSCT PERIOD TO 2 YEARS POST HSCT (IND 14359)
    Braniecki, Suzanne
    Parsons, Susan K.
    Shenoy, Shalini
    Shi, Qiuhu
    Moore, Theodore B.
    Talano, Julie-An
    Flower, Allyson
    Panarella, Anne
    Fabricatore, Sandra
    Morris, Erin
    Milner, Jordan
    McKinstry, Robert C.
    Cairo, Mitchell S.
    [J]. PEDIATRIC BLOOD & CANCER, 2020, 67 : S223 - S224